Big Pharma's Foe Takes Victory Lap as Drug Price Increases Slow
- Express Scripts CEO to retire, making way for successor
- Prices rise 0.7% in second quarter including rebates, SSR says
This article is for subscribers only.
Just as he’s about to retire, George Paz’s strategy to rein in drug companies’ price increases is starting to show results.
A new analysis shows that attempts by drugmakers to raise prices on their prescription medications are being wiped out in negotiations with managers of drug insurance benefits, led by Paz’s company, Express Scripts Holding Co., and his biggest rival, CVS Health Corp. Express Scripts said Wednesday that Paz will retire in May, making way for the company’s president, Tim Wentworth, to take over.